Warning to be put in Avandia, Actos

The Korea Food and Drug Administration said on June 12 that it instructed GlaxoSmithKline and Lilly Korea to add the warning to the instructions of Avandia and Actos, following widely publicized medical report that suggested it increases risk of heart attack.

Avandia, one of GSK biggest products, is a member of the thiazolidinedione (TZD) class of diabetes drugs that also includes Takeda Pha...